We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Robotic System Selectively Kills Microscopic Tumor Cells without Damaging Surrounding Tissue

By HospiMedica International staff writers
Posted on 25 Sep 2023
Print article
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)

When treating cancer, surgeons usually aim to remove the tumor along with a surrounding "margin" of healthy tissue to make sure all cancer cells have been taken out. However, even with advancements in different types of treatments like surgery, chemotherapy, and immunotherapy, there's still no absolute assurance that microscopic cancer cells aren't left behind in the surgical margins. These lingering cells can contribute to cancer returning and worsen survival rates. Now, the world’s first AI robotic system selectively targets and kills microscopic tumor cells during surgery without damaging non-cancerous surrounding tissue.

The Canady Robotic AI Surgical System from the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS, Takoma Park, MD, USA) and US Medical Innovations, LLC (USMI, Takoma Park, MD, USA) marks a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System delivers cold atmospheric plasma (CAP) which is a three-dimensional non-contact bioelectric pulse electromagnetic field that selectively targets cancer cells at the surgical margin.

The key components of the Canady Robotic AI Surgical System include a motorized positioning arm, speech recognition Canady electrosurgical generator known as ORLI, controller for CAP devices, robotic-assisted end effectors which can be used in open, laparoscopic, thoracoscopic, endoscopic, and mini-invasive surgical procedures. The system also provides surgeons with 10 degrees of freedom, speech activation of the robotic movements, AI-powered software programs, 3D navigational guided surgical planning, advanced contour tracking of the CAP beam, and pre-programmed CAP dosimetry data for selectively targeting 32 cancer cell types, all in a compact and mobile design.

“This technology will transform the landscape of the OR. ORLI is a user-friendly system controlling the entire integrated SMART Operating Room. The platform will serve as a SIRI, ALEXA, and GOOGLE HOME for the operating room,” said Jerome Canady, MD, FACS, CEO and Surgical Oncologist. “Data collected from our recent FDA Phase 1 Clinical Trial on Stage 4 Cancer Patients combined with ten years of in-vitro translational molecular research data have been imported into the Canady Robotic AI Surgical System. This achievement signifies a significant leap forward integrating artificial intelligence and robotics in surgery.”

Related Links:
JCRI-ABTS 

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Specimen Collection & Transport
New
Clinical Information System
MICRELCARE
Gold Supplier
POC Blood Gas Analyzer
Stat Profile Prime Plus

Print article
Detecto

Channels

Critical Care

view channel
Image: Real-time machine learning model predicts in-hospital cardiac arrest using heart rate variability in ICU (Photo courtesy of 123RF)

Machine Learning Model Accurately Predicts Cardiac Arrest in ICU Patients Using ECG Data

Cardiac arrest within hospital settings, particularly in Intensive Care Units (ICUs), remains a significant challenge, occurring in 0.5–7.8% of patients upon hospital admission. Despite advancements in... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The patented 3TR technology delivers proven PCR-level sensitivity and specificity (Photo courtesy of 3EO Health)

High-Performing Low-Cost Diagnostic Platform Provides Molecular Results At Near Antigen Pricing

When it comes to point-of-care respiratory diagnostic products, there's often a trade-off between performance and affordability. Current molecular diagnostic solutions are high-performing but expensive... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.